TWIST1 and acute myeloid leukemia: Contrary to this, another discovery indicated that the enforced overexpression of TWIST1 in AML cell lines (K562 and U937) enhanced the resistance activity to imatinib, mitoxantrone, and daunorubicin; the study further found that a higher expression of TWIST1 was linked with a worse overall survival in the AML samples.